Prevention of Intradialytic Hypotension by Inhibiting Bradykinin B2 Receptor

Clinical trial NCT05834777 · RECRUITING

Trial details

NCT number: NCT05834777
Sponsor: Vanderbilt University Medical Center
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Intradialytic Hypotension

Start date: 2023-12-11
Primary completion: 2026-07-01
Enrollment: 26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.